Alvotech: New Chief Quality Officer

Alvotech, a biotech specializing in the development and manufacture of biosimilars, has announced that Sarah Tanksley will join its corporate leadership team as Chief Quality Officer, effective October 14. 

Tanksley succeeds Reem Malki, who is stepping down for personal reasons.

Tanksley has been working with Alvotech as a consultant and her familiarity with the company will help ensure a smooth transition, alongside her experience in regulatory compliance and GMP.

Ms. Tanksley has 20 years of experience within the U.S. National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), and as an industry consultant. She teaches graduate courses in GMP compliance and Regulatory Affairs as an Adjunct Professor in the Graduate Biochemistry and Molecular Biology Program at Georgetown University School of Medicine and with the Advanced Academic Program at Johns Hopkins University. Sarah has an MS degree in Bioscience Regulatory Affairs from Johns Hopkins University, as well as an MS degree in Biochemistry and Molecular Biology from Georgetown University School of Medicine.